Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_assertion type Assertion NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_head.
- NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_assertion description "[Among human breast cancers, MET is primarily elevated in basal and ERBB2-positive subtypes with poor prognosis, and we show that MET, together with EMT marker, SNAIL, are highly predictive of poor prognosis in lymph node-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_provenance.
- NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_assertion evidence source_evidence_literature NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_provenance.
- NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_assertion SIO_000772 19617568 NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_provenance.
- NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_assertion wasDerivedFrom befree-20140225 NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_provenance.
- NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_assertion wasGeneratedBy ECO_0000203 NP894194.RATdgXfwP5M18_9C5x4bjSNr18NYVjSmfiJgMvMewJLMc130_provenance.